Improving Evidence-Based Care for Cancer Patients
- Conditions
- Head and Neck CancerLung CancerGynecologic CancerGastrointestinal CancerProstate CancerBreast Cancer
- Interventions
- Other: SurveyOther: Saliva sampleOther: Smoking Status questions
- Registration Number
- NCT03207594
- Lead Sponsor
- Medical University of South Carolina
- Brief Summary
The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 128
- Diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancer
- 21 years of age or older at time of study registration
- Must have been referred to MUSC radiation oncology for treatment with curative radiation therapy
- Must report current smoking defined as self-reporting smoking within the past 30 days using a structured intake questionnaire.
- Patients with primary central nervous system malignancies will be excluded.
- Patients that have other cancer disease types will be excluded due to either significant differences in standard radiation therapy approaches or rarity of disease required radiation.
- Patients who are currently participating in the Medical University of South Carolina Hollings Cancer Center smoking cessation program
- Patients who are unable to provide informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Arm 1 Saliva sample Current smokers with cancer who are planning to get radiation therapy at MUSC. Arm 1 Survey Current smokers with cancer who are planning to get radiation therapy at MUSC. Arm 1 Smoking Status questions Current smokers with cancer who are planning to get radiation therapy at MUSC.
- Primary Outcome Measures
Name Time Method Number of patients with biochemically confirmed smoking cessation 4 weeks after enrollment Biochemical confirmation will be determined by saliva samples
Number of patient who self-report smoking cessation 4 weeks after enrollment Self-reported smoking cessation will be documented via smoking assessment questionnaire
- Secondary Outcome Measures
Name Time Method Average weekly smoke exposure up to 62 weeks reported cigarettes per day multiplied by the number of days smoked during radiation therapy (RT), summed over a period of time and normalized to yield an average weekly smoke exposure during RT.
Number of patients who participate in smoking cessation up to 12 months after completion of RT. Completing one in-person visit where an individualized smoking cessation treatment plan is developed and implemented.
Compliance with smoking cessation up to 12 weeks after completion of RT Two binary measure of compliance:
1. - completing at least three in person visits within 6 weeks of starting an individualized cessation treatment plan
2. - completing at least one in-person visit and at least two phone-based communications
Trial Locations
- Locations (1)
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States